US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

InflaRx N.V.

0.8949

+0.06958.42%

Post-market: 0.8722-0.0227-2.54%19:35 EST

Volume:637.42K

Turnover:559.32K

Market Cap:60.63M

PE:-1.23

High:0.9000

Open:0.8449

Low:0.8263

Close:0.8254

52wk High:2.77

52wk Low:0.7113

Shares:67.75M

Float Shares:56.94M

Volume Ratio:1.25

T/O Rate:1.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7298

EPS(LYR):-0.8094

ROE:-72.49%

ROA:-40.69%

PB:1.13

PE(LYR):-1.11

Loading ...

Overview Company News Filings

Here's Why We're A Bit Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Situation

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), InflaRx (IFRX) and Verastem (VSTM)

InflaRx NV to Present at Guggenheim Securities Emerging Outlook Biotech Summit

InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway

Benzinga_recent_news

InflaRx NV to Prioritize Izicopan Development in Hidradenitis Suppurativa and I&I, Plans Workforce Reduction, China PK Bridging Study, and Cost Structure Optimization to Extend Cash Runway to Mid-2027

InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder

InflaRx Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum

InflaRx Reviews Phase 3 Data for Vilobelimab in Pyoderma Gangrenosum After Early Trial Termination

InflaRx Is Maintained at Buy by Guggenheim

InflaRx Reports Positive Phase 2a Results for INF904 in HS and CSU

InflaRx NV expected to post a loss of 15 cents a share - Earnings Preview

InflaRx (IFRX) Receives a Buy from Leerink Partners

H.C. Wainwright Remains a Buy on InflaRx (IFRX)

InflaRx regains compliance with Nasdaq min bid price requirement

InflaRx Coverage Assumed by HC Wainwright & Co. at Buy

InflaRx Nv : H.c. Wainwright Assumes Coverage With Buy Rating; Price Target $6

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IFRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IFRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IFRX\",,,,,undefined,":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":0.8949,"timestamp":1770411600000,"preClose":0.8254,"halted":0,"volume":637421,"hourTrading":{"tag":"盘后","latestPrice":0.8722,"preClose":0.8949,"latestTime":"19:35 EST","volume":2210,"amount":1965.0337,"timestamp":1770424513065,"change":-0.0227,"changeRate":-0.025366,"amplitude":0.048721},"delay":0,"changeRate":0.08420159922461837,"floatShares":56940731,"shares":67747130,"eps":-0.729824,"marketStatus":"Market Closed","change":0.0695,"latestTime":"02-06 16:00:00 EST","open":0.8449,"high":0.9,"low":0.8263,"amount":559321.7568802,"amplitude":0.08929,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.729824,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1510117200000,"exchange":"NASDAQ","adjPreClose":0.8254,"preHourTrading":{"tag":"盘前","latestPrice":0.8448,"preClose":0.8254,"latestTime":"09:07 EST","volume":882,"amount":720.1059894,"timestamp":1770386867558,"change":0.0194,"changeRate":0.023504,"amplitude":0.039738},"postHourTrading":{"tag":"盘后","latestPrice":0.8722,"preClose":0.8949,"latestTime":"19:35 EST","volume":2210,"amount":1965.0337,"timestamp":1770424513065,"change":-0.0227,"changeRate":-0.025366,"amplitude":0.048721},"volumeRatio":1.245666188762423,"impliedVol":2.8706,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IFRX\",,,,,undefined,":{"symbol":"IFRX","floatShares":56940731,"roa":"-40.69%","roe":"-72.49%","lyrEps":-0.809414,"volumeRatio":1.245666188762423,"shares":67747130,"dividePrice":0,"high":0.9,"amplitude":0.08929,"preClose":0.8254,"low":0.8263,"week52Low":0.7113,"pbRate":"1.13","psRate":"816.41","week52High":2.77,"institutionHeld":0,"latestPrice":0.8949,"eps":-0.729824,"divideRate":0,"volume":637421,"delay":0,"ttmEps":-0.729824,"open":0.8449,"prevYearClose":1.01,"prevWeekClose":0.8821,"prevMonthClose":0.8821,"prevQuarterClose":1.01,"fiveDayClose":0.8821,"twentyDayClose":1.09,"sixtyDayClose":1.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IFRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"IFRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-08-07","symbol":"IFRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2025-05-07","symbol":"IFRX","fiscalQuarterEnding":"2025/03","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-03-20","symbol":"IFRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2024-11-08","symbol":"IFRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IFRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IFRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":8,"updateTime":1767157200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IFRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IFRX","date":"2026-02-06","current":-1.226186,"percent":0.905583,"low":-9.450046,"twenty":-3.615874,"median":-2.454336,"eighty":-1.599547,"high":-0.61166,"avg":-2.87261,"sd":1.773563,"marketCap":55918481},"quantilePoints":[{"date":"2021-02-12","current":-3.442339,"twenty":-26.350016,"median":-3.369392,"eighty":-2.029032,"marketCap":161748817},{"date":"2021-02-19","current":-3.390575,"twenty":-26.335027,"median":-3.378227,"eighty":-2.030758,"marketCap":159490544},{"date":"2021-02-26","current":-3.878393,"twenty":-26.313621,"median":-3.377505,"eighty":-2.035569,"marketCap":181929513},{"date":"2021-03-05","current":-3.777574,"twenty":-26.288264,"median":-3.390575,"eighty":-2.040517,"marketCap":174476979},{"date":"2021-03-12","current":-4.535003,"twenty":-26.279121,"median":-3.401803,"eighty":-2.044284,"marketCap":209986113},{"date":"2021-03-19","current":-4.370201,"twenty":-26.276693,"median":-3.415068,"eighty":-2.050341,"marketCap":201656810},{"date":"2021-03-26","current":-4.440748,"twenty":-26.274543,"median":-3.440746,"eighty":-2.053956,"marketCap":177984054},{"date":"2021-04-01","current":-4.429295,"twenty":-26.269968,"median":-3.46826,"eighty":-2.054735,"marketCap":177107285},{"date":"2021-04-09","current":-4.059861,"twenty":-26.251921,"median":-3.480591,"eighty":-2.057792,"marketCap":163955754},{"date":"2021-04-16","current":-3.984462,"twenty":-26.218314,"median":-3.527908,"eighty":-2.061994,"marketCap":162202216},{"date":"2021-04-23","current":-4.010732,"twenty":-26.193443,"median":-3.558239,"eighty":-2.063045,"marketCap":164394138},{"date":"2021-04-30","current":-4.074993,"twenty":-26.184143,"median":-3.591785,"eighty":-2.06359,"marketCap":166586060},{"date":"2021-05-07","current":-3.842274,"twenty":-26.139294,"median":-3.614662,"eighty":-2.064579,"marketCap":158695141},{"date":"2021-05-14","current":-3.186455,"twenty":-26.086829,"median":-3.611445,"eighty":-2.067041,"marketCap":123279718},{"date":"2021-05-21","current":-3.355287,"twenty":-26.047911,"median":-3.575432,"eighty":-2.069216,"marketCap":130349523},{"date":"2021-05-28","current":-3.469026,"twenty":-25.99014,"median":-3.558383,"eighty":-2.070932,"marketCap":134768150},{"date":"2021-06-04","current":-3.566091,"twenty":-25.964006,"median":-3.551138,"eighty":-2.073369,"marketCap":138303053},{"date":"2021-06-11","current":-3.518159,"twenty":-25.885062,"median":-3.557413,"eighty":-2.074827,"marketCap":135651876},{"date":"2021-06-18","current":-3.753351,"twenty":-25.88379,"median":-3.562309,"eighty":-2.080139,"marketCap":141837955},{"date":"2021-06-25","current":-3.563269,"twenty":-25.880672,"median":-3.558526,"eighty":-2.082922,"marketCap":135651876},{"date":"2021-07-02","current":-3.499843,"twenty":-25.869428,"median":-3.550988,"eighty":-2.083725,"marketCap":132116974},{"date":"2021-07-09","current":-3.271623,"twenty":-25.854824,"median":-3.543737,"eighty":-2.085499,"marketCap":123721581},{"date":"2021-07-16","current":-3.064092,"twenty":-25.824946,"median":-3.525504,"eighty":-2.095381,"marketCap":115326188},{"date":"2021-07-23","current":-3.158159,"twenty":-25.776691,"median":-3.509001,"eighty":-2.102832,"marketCap":118419227},{"date":"2021-07-30","current":-3.038296,"twenty":-25.773994,"median":-3.481606,"eighty":-2.104736,"marketCap":114884325},{"date":"2021-08-06","current":-2.687181,"twenty":-25.749354,"median":-3.480271,"eighty":-2.111424,"marketCap":115768050},{"date":"2021-08-13","current":-2.463946,"twenty":-25.738927,"median":-3.472316,"eighty":-2.113319,"marketCap":106488932},{"date":"2021-08-20","current":-2.375348,"twenty":-25.71506,"median":-3.463394,"eighty":-2.119172,"marketCap":101628441},{"date":"2021-08-27","current":-2.619465,"twenty":-25.692402,"median":-3.442339,"eighty":-2.121987,"marketCap":113116874},{"date":"2021-09-03","current":-2.629539,"twenty":-25.687287,"median":-3.426387,"eighty":-2.124476,"marketCap":114442462},{"date":"2021-09-10","current":-3.008915,"twenty":-25.681175,"median":-3.41157,"eighty":-2.126692,"marketCap":130349523},{"date":"2021-09-17","current":-2.80593,"twenty":-25.674949,"median":-3.397053,"eighty":-2.130135,"marketCap":120628541},{"date":"2021-09-24","current":-2.740723,"twenty":-25.665585,"median":-3.389807,"eighty":-2.134706,"marketCap":117535502},{"date":"2021-10-01","current":-2.664251,"twenty":-25.645992,"median":-3.376783,"eighty":-2.138732,"marketCap":113116874},{"date":"2021-10-08","current":-2.804412,"twenty":-25.638419,"median":-3.369345,"eighty":-2.139942,"marketCap":118861090},{"date":"2021-10-15","current":-2.568797,"twenty":-25.59942,"median":-3.355287,"eighty":-2.15103,"marketCap":109140109},{"date":"2021-10-22","current":-3.059811,"twenty":-25.561641,"median":-3.349052,"eighty":-2.154896,"marketCap":130349523},{"date":"2021-10-29","current":-4.423919,"twenty":-25.544343,"median":-3.348306,"eighty":-2.158087,"marketCap":187349822},{"date":"2021-11-05","current":-4.251839,"twenty":-25.536207,"median":-3.352563,"eighty":-2.163381,"marketCap":205466197},{"date":"2021-11-12","current":-5.149963,"twenty":-25.532701,"median":-3.369298,"eighty":-2.165514,"marketCap":246559436},{"date":"2021-11-19","current":-4.442446,"twenty":-25.494082,"median":-3.373909,"eighty":-2.169524,"marketCap":210326688},{"date":"2021-11-26","current":-4.743245,"twenty":-25.480025,"median":-3.383633,"eighty":-2.171417,"marketCap":224466297},{"date":"2021-12-03","current":-3.8471,"twenty":-25.476764,"median":-3.39115,"eighty":-2.172284,"marketCap":181605606},{"date":"2021-12-10","current":-3.950486,"twenty":-25.466679,"median":-3.407313,"eighty":-2.174154,"marketCap":186907960},{"date":"2021-12-17","current":-3.992006,"twenty":-25.456835,"median":-3.415357,"eighty":-2.176712,"marketCap":188233548},{"date":"2021-12-23","current":-4.34175,"twenty":-25.447224,"median":-3.439152,"eighty":-2.178157,"marketCap":205466197},{"date":"2021-12-31","current":-4.422329,"twenty":-25.434421,"median":-3.460422,"eighty":-2.181429,"marketCap":210326688},{"date":"2022-01-07","current":-3.615004,"twenty":-25.4299,"median":-3.469026,"eighty":-2.186377,"marketCap":171442762},{"date":"2022-01-14","current":-3.931443,"twenty":-25.423348,"median":-3.476311,"eighty":-2.188634,"marketCap":187791685},{"date":"2022-01-21","current":-3.27922,"twenty":-25.415798,"median":-3.480271,"eighty":-2.18983,"marketCap":155535702},{"date":"2022-01-28","current":-3.332032,"twenty":-25.405586,"median":-3.472316,"eighty":-2.191659,"marketCap":155535702},{"date":"2022-02-04","current":-3.277911,"twenty":-25.393185,"median":-3.463394,"eighty":-2.191987,"marketCap":156861290},{"date":"2022-02-11","current":-3.094239,"twenty":-25.349416,"median":-3.457906,"eighty":-2.192343,"marketCap":147582171},{"date":"2022-02-18","current":-2.908888,"twenty":-25.342061,"median":-3.438284,"eighty":-2.19268,"marketCap":137861190},{"date":"2022-02-25","current":-2.822869,"twenty":-25.330025,"median":-3.426102,"eighty":-2.193365,"marketCap":133000699},{"date":"2022-03-04","current":-2.042583,"twenty":-25.326961,"median":-3.408072,"eighty":-2.192509,"marketCap":93233048},{"date":"2022-03-11","current":-1.881926,"twenty":-25.319085,"median":-3.394102,"eighty":-2.189491,"marketCap":86163244},{"date":"2022-03-18","current":-2.091797,"twenty":-25.313085,"median":-3.389039,"eighty":-2.185207,"marketCap":96767951},{"date":"2022-03-25","current":-2.212947,"twenty":-25.309822,"median":-3.373909,"eighty":-2.178911,"marketCap":110951445},{"date":"2022-04-01","current":-1.667593,"twenty":-25.302123,"median":-3.369298,"eighty":-2.172439,"marketCap":83987149},{"date":"2022-04-08","current":-1.558658,"twenty":-25.300371,"median":-3.359638,"eighty":-2.164523,"marketCap":77356585},{"date":"2022-04-14","current":-1.613479,"twenty":-25.284057,"median":-3.352563,"eighty":-2.153506,"marketCap":79566773},{"date":"2022-04-22","current":-1.590703,"twenty":-25.274805,"median":-3.348306,"eighty":-2.139942,"marketCap":78240660},{"date":"2022-04-29","current":-1.553514,"twenty":-25.247442,"median":-3.341568,"eighty":-2.130135,"marketCap":74704359},{"date":"2022-05-06","current":-1.463033,"twenty":-25.232905,"median":-3.334919,"eighty":-2.118001,"marketCap":70726020},{"date":"2022-05-13","current":-1.158755,"twenty":-25.216013,"median":-3.326309,"eighty":-2.104355,"marketCap":64537493},{"date":"2022-05-20","current":-1.127654,"twenty":-25.153392,"median":-3.312666,"eighty":-2.090537,"marketCap":63653418},{"date":"2022-05-27","current":-1.133538,"twenty":-25.123387,"median":-3.307821,"eighty":-2.078473,"marketCap":64979531},{"date":"2022-06-03","current":-1.133052,"twenty":-25.102901,"median":-3.297547,"eighty":-2.071719,"marketCap":64979531},{"date":"2022-06-10","current":-1.099107,"twenty":-25.078955,"median":-3.285676,"eighty":-2.064881,"marketCap":61885268},{"date":"2022-06-17","current":-0.95534,"twenty":-25.058012,"median":-3.278566,"eighty":-2.059013,"marketCap":53486553},{"date":"2022-06-24","current":-0.61166,"twenty":-25.013779,"median":-3.274146,"eighty":-2.050697,"marketCap":34523138},{"date":"2022-07-01","current":-1.143714,"twenty":-24.953195,"median":-3.27019,"eighty":-2.039731,"marketCap":63653418},{"date":"2022-07-08","current":-1.249984,"twenty":-24.940061,"median":-3.266364,"eighty":-2.028029,"marketCap":68073795},{"date":"2022-07-15","current":-1.105244,"twenty":-24.912512,"median":-3.253607,"eighty":-2.016954,"marketCap":59675080},{"date":"2022-07-22","current":-1.090969,"twenty":-24.825431,"median":-3.232562,"eighty":-1.98678,"marketCap":59675080},{"date":"2022-07-29","current":-2.219243,"twenty":-24.705558,"median":-3.220144,"eighty":-1.924555,"marketCap":121118310},{"date":"2022-08-05","current":-3.310261,"twenty":-24.665355,"median":-3.208176,"eighty":-1.952888,"marketCap":128632950},{"date":"2022-08-12","current":-3.369138,"twenty":-24.623821,"median":-3.226312,"eighty":-1.980182,"marketCap":132169251},{"date":"2022-08-19","current":-2.876794,"twenty":-24.618574,"median":-3.208176,"eighty":-1.98678,"marketCap":110509407},{"date":"2022-08-26","current":-2.62393,"twenty":-24.606349,"median":-3.198154,"eighty":-2.009536,"marketCap":100342542},{"date":"2022-09-02","current":-2.648776,"twenty":-24.583084,"median":-3.186455,"eighty":-2.011689,"marketCap":101668654},{"date":"2022-09-09","current":-3.268037,"twenty":-24.575807,"median":-3.180921,"eighty":-2.016029,"marketCap":125538686},{"date":"2022-09-16","current":-3.112552,"twenty":-24.525387,"median":-3.168258,"eighty":-2.016818,"marketCap":119350160},{"date":"2022-09-23","current":-2.519124,"twenty":-24.51136,"median":-3.149642,"eighty":-2.017498,"marketCap":93711977},{"date":"2022-09-30","current":-3.110486,"twenty":-24.503768,"median":-3.141488,"eighty":-2.023142,"marketCap":116697934},{"date":"2022-10-07","current":-3.001762,"twenty":-24.499937,"median":-3.125003,"eighty":-2.026815,"marketCap":112277558},{"date":"2022-10-14","current":-2.833329,"twenty":-24.463679,"median":-3.11616,"eighty":-2.027695,"marketCap":105646993},{"date":"2022-10-21","current":-2.968518,"twenty":-24.434266,"median":-3.112552,"eighty":-2.029366,"marketCap":111393482},{"date":"2022-10-28","current":-3.044242,"twenty":-24.387783,"median":-3.104843,"eighty":-2.031686,"marketCap":115813859},{"date":"2022-11-04","current":-2.925419,"twenty":-24.386265,"median":-3.100143,"eighty":-2.034524,"marketCap":110951445},{"date":"2022-11-11","current":-3.360927,"twenty":-24.374133,"median":-3.104843,"eighty":-2.038158,"marketCap":118466084},{"date":"2022-11-18","current":-3.187327,"twenty":-24.357612,"median":-3.106216,"eighty":-2.04209,"marketCap":112719595},{"date":"2022-11-25","current":-3.114145,"twenty":-24.321314,"median":-3.103471,"eighty":-2.042484,"marketCap":110509407},{"date":"2022-12-02","current":-3.199416,"twenty":-24.305952,"median":-3.109484,"eighty":-2.045113,"marketCap":114487746},{"date":"2022-12-09","current":-2.839171,"twenty":-24.296418,"median":-3.103471,"eighty":-2.048262,"marketCap":102110692},{"date":"2022-12-16","current":-2.626368,"twenty":-24.268656,"median":-3.098225,"eighty":-2.052502,"marketCap":95038090},{"date":"2022-12-23","current":-3.963354,"twenty":-24.249087,"median":-3.100143,"eighty":-2.05414,"marketCap":143662229},{"date":"2022-12-30","current":-3.757141,"twenty":-24.236402,"median":-3.103471,"eighty":-2.05494,"marketCap":137031665},{"date":"2023-01-06","current":-3.429325,"twenty":-24.187068,"median":-3.103471,"eighty":-2.05494,"marketCap":124212574},{"date":"2023-01-13","current":-3.148676,"twenty":-24.119807,"median":-3.103471,"eighty":-2.05494,"marketCap":116255896},{"date":"2023-01-20","current":-2.87463,"twenty":-24.060794,"median":-3.095243,"eighty":-2.05494,"marketCap":106310050},{"date":"2023-01-27","current":-2.684699,"twenty":-23.889509,"median":-3.081171,"eighty":-2.05494,"marketCap":99458466},{"date":"2023-02-03","current":-2.625894,"twenty":-23.753924,"median":-3.075373,"eighty":-2.05494,"marketCap":97248278},{"date":"2023-02-10","current":-2.437904,"twenty":-23.637734,"median":-3.064648,"eighty":-2.05494,"marketCap":88849563},{"date":"2023-02-17","current":-2.733077,"twenty":-23.443338,"median":-3.059811,"eighty":-2.05494,"marketCap":99458466},{"date":"2023-02-24","current":-2.504414,"twenty":-23.240436,"median":-3.05296,"eighty":-2.05494,"marketCap":90175676},{"date":"2023-03-03","current":-2.223958,"twenty":-23.091745,"median":-3.042742,"eighty":-2.05494,"marketCap":80450848},{"date":"2023-03-10","current":-2.185996,"twenty":-22.971614,"median":-3.031527,"eighty":-2.05494,"marketCap":79566773},{"date":"2023-03-17","current":-2.017049,"twenty":-22.749108,"median":-3.015708,"eighty":-2.053956,"marketCap":73378246},{"date":"2023-03-24","current":-2.536982,"twenty":-22.567429,"median":-3.002572,"eighty":-2.051599,"marketCap":80466773},{"date":"2023-03-31","current":-2.707242,"twenty":-22.293774,"median":-2.985327,"eighty":-2.052502,"marketCap":86725300},{"date":"2023-04-06","current":-8.468992,"twenty":-22.221188,"median":-2.980368,"eighty":-2.050697,"marketCap":272692954},{"date":"2023-04-19","current":-7.539816,"twenty":-21.900043,"median":-2.966913,"eighty":-2.045113,"marketCap":243679193},{"date":"2023-04-28","current":-8.425592,"twenty":-21.574969,"median":-2.964258,"eighty":-2.043848,"marketCap":273807214},{"date":"2023-05-05","current":-8.149129,"twenty":-21.326308,"median":-2.964258,"eighty":-2.043848,"marketCap":264385891},{"date":"2023-05-12","current":-8.961759,"twenty":-21.165358,"median":-2.964258,"eighty":-2.043848,"marketCap":288528032},{"date":"2023-05-19","current":-8.105007,"twenty":-20.576815,"median":-2.964258,"eighty":-2.043848,"marketCap":257319898},{"date":"2023-05-26","current":-7.634536,"twenty":-18.895891,"median":-2.964258,"eighty":-2.043848,"marketCap":241421415},{"date":"2023-06-02","current":-8.897592,"twenty":-17.2313,"median":-2.964258,"eighty":-2.043848,"marketCap":253786902},{"date":"2023-06-09","current":-8.238655,"twenty":-8.997075,"median":-2.964258,"eighty":-2.043848,"marketCap":235827504},{"date":"2023-06-16","current":-9.028798,"twenty":-8.93681,"median":-2.964258,"eighty":-2.043848,"marketCap":262030560},{"date":"2023-06-23","current":-9.140768,"twenty":-8.899027,"median":-2.963209,"eighty":-2.043216,"marketCap":266152389},{"date":"2023-06-30","current":-9.039015,"twenty":-8.897592,"median":-2.962755,"eighty":-2.042583,"marketCap":261441727},{"date":"2023-07-07","current":-7.957828,"twenty":-8.77461,"median":-2.962755,"eighty":-2.042583,"marketCap":229644760},{"date":"2023-07-14","current":-8.574185,"twenty":-8.60592,"median":-2.962755,"eighty":-2.042583,"marketCap":254964567},{"date":"2023-07-21","current":-8.113503,"twenty":-8.47995,"median":-2.962755,"eighty":-2.042583,"marketCap":240243749},{"date":"2023-07-28","current":-8.208184,"twenty":-8.435717,"median":-2.962755,"eighty":-2.042583,"marketCap":239654917},{"date":"2023-08-04","current":-8.299584,"twenty":-8.360313,"median":-2.962755,"eighty":-2.042583,"marketCap":241421415},{"date":"2023-08-11","current":-6.068497,"twenty":-8.239877,"median":-2.962755,"eighty":-2.042583,"marketCap":235533088},{"date":"2023-08-18","current":-5.82274,"twenty":-8.188318,"median":-2.962755,"eighty":-2.042583,"marketCap":223167600},{"date":"2023-08-25","current":-5.909797,"twenty":-8.105007,"median":-2.962755,"eighty":-2.042583,"marketCap":225522931},{"date":"2023-09-01","current":-6.086379,"twenty":-7.942756,"median":-2.962301,"eighty":-2.042484,"marketCap":232588924},{"date":"2023-09-08","current":-6.122042,"twenty":-7.841561,"median":-2.962301,"eighty":-2.042484,"marketCap":230822426},{"date":"2023-09-15","current":-6.047691,"twenty":-7.657546,"median":-2.962301,"eighty":-2.042484,"marketCap":227289429},{"date":"2023-09-22","current":-4.87418,"twenty":-7.215475,"median":-2.960275,"eighty":-2.042386,"marketCap":183126975},{"date":"2023-09-29","current":-4.665817,"twenty":-6.271729,"median":-2.960275,"eighty":-2.042386,"marketCap":173705652},{"date":"2023-10-06","current":-4.095273,"twenty":-6.07565,"median":-2.960275,"eighty":-2.042386,"marketCap":151918841},{"date":"2023-10-13","current":-3.864893,"twenty":-5.857563,"median":-2.960275,"eighty":-2.042386,"marketCap":143675183},{"date":"2023-10-20","current":-3.286668,"twenty":-5.646626,"median":-2.960275,"eighty":-2.042386,"marketCap":122477205},{"date":"2023-10-27","current":-2.697868,"twenty":-5.537504,"median":-2.950514,"eighty":-2.04209,"marketCap":100101562},{"date":"2023-11-03","current":-2.233806,"twenty":-5.197421,"median":-2.928023,"eighty":-2.04209,"marketCap":82436580},{"date":"2023-11-10","current":-2.087155,"twenty":-4.907963,"median":-2.91242,"eighty":-2.04209,"marketCap":77725919},{"date":"2023-11-17","current":-2.261025,"twenty":-4.743245,"median":-2.905286,"eighty":-2.034524,"marketCap":85380744},{"date":"2023-11-24","current":-2.252183,"twenty":-4.665817,"median":-2.892865,"eighty":-2.034524,"marketCap":85380744},{"date":"2023-12-01","current":-2.096632,"twenty":-4.532206,"median":-2.879719,"eighty":-2.031686,"marketCap":79492417},{"date":"2023-12-08","current":-2.197999,"twenty":-4.48737,"median":-2.868186,"eighty":-2.032254,"marketCap":82436580},{"date":"2023-12-15","current":-2.110521,"twenty":-4.438457,"median":-2.833849,"eighty":-2.032254,"marketCap":80670082},{"date":"2023-12-22","current":-2.280481,"twenty":-4.370666,"median":-2.82501,"eighty":-2.031763,"marketCap":87147242},{"date":"2023-12-29","current":-2.538435,"twenty":-4.33424,"median":-2.816208,"eighty":-2.031686,"marketCap":97746231},{"date":"2024-01-05","current":-2.828463,"twenty":-4.286188,"median":-2.805171,"eighty":-2.031222,"marketCap":107756387},{"date":"2024-01-12","current":-2.707482,"twenty":-4.256229,"median":-2.79763,"eighty":-2.031222,"marketCap":103045726},{"date":"2024-01-19","current":-2.494382,"twenty":-4.232858,"median":-2.773571,"eighty":-2.030758,"marketCap":94213235},{"date":"2024-01-26","current":-2.344327,"twenty":-4.195043,"median":-2.765202,"eighty":-2.031222,"marketCap":88324908},{"date":"2024-02-02","current":-2.654313,"twenty":-4.16251,"median":-2.743527,"eighty":-2.031222,"marketCap":100101562},{"date":"2024-02-09","current":-2.486219,"twenty":-4.136824,"median":-2.732222,"eighty":-2.031222,"marketCap":93035569},{"date":"2024-02-16","current":-2.42458,"twenty":-4.095212,"median":-2.710198,"eighty":-2.031222,"marketCap":90680238},{"date":"2024-02-23","current":-2.301923,"twenty":-4.077605,"median":-2.703082,"eighty":-2.031222,"marketCap":86558409},{"date":"2024-03-01","current":-2.789171,"twenty":-4.072563,"median":-2.697868,"eighty":-2.031686,"marketCap":104812224},{"date":"2024-03-08","current":-2.572738,"twenty":-4.024419,"median":-2.697241,"eighty":-2.031686,"marketCap":97746231},{"date":"2024-03-15","current":-2.363742,"twenty":-4.006418,"median":-2.688162,"eighty":-2.031686,"marketCap":89502573},{"date":"2024-03-22","current":-1.957166,"twenty":-3.989235,"median":-2.683334,"eighty":-2.029366,"marketCap":90680238},{"date":"2024-03-28","current":-1.96758,"twenty":-3.977045,"median":-2.670879,"eighty":-2.026815,"marketCap":90680238},{"date":"2024-04-05","current":-1.981938,"twenty":-3.964341,"median":-2.658011,"eighty":-2.01666,"marketCap":91857904},{"date":"2024-04-12","current":-1.984369,"twenty":-3.932271,"median":-2.654637,"eighty":-1.983883,"marketCap":90680238},{"date":"2024-04-19","current":-1.630704,"twenty":-3.866737,"median":-2.638291,"eighty":-1.97026,"marketCap":74192922},{"date":"2024-04-26","current":-1.790703,"twenty":-3.836036,"median":-2.634291,"eighty":-1.962479,"marketCap":81847748},{"date":"2024-05-03","current":-1.780105,"twenty":-3.78565,"median":-2.628724,"eighty":-1.946126,"marketCap":81258915},{"date":"2024-05-10","current":-1.590155,"twenty":-3.773538,"median":-2.625321,"eighty":-1.897734,"marketCap":70659926},{"date":"2024-05-17","current":-1.904668,"twenty":-3.753351,"median":-2.61868,"eighty":-1.886655,"marketCap":85380744},{"date":"2024-05-24","current":-1.952316,"twenty":-3.735549,"median":-2.606627,"eighty":-1.886655,"marketCap":87147242},{"date":"2024-05-31","current":-1.882889,"twenty":-3.684127,"median":-2.593785,"eighty":-1.882889,"marketCap":84203078},{"date":"2024-06-07","current":-2.112539,"twenty":-3.653656,"median":-2.588348,"eighty":-1.881926,"marketCap":94802067},{"date":"2024-06-14","current":-2.016149,"twenty":-3.654543,"median":-2.588093,"eighty":-1.881261,"marketCap":89502573},{"date":"2024-06-21","current":-1.971968,"twenty":-3.65543,"median":-2.585869,"eighty":-1.880596,"marketCap":87147242},{"date":"2024-06-28","current":-2.227273,"twenty":-3.658092,"median":-2.588093,"eighty":-1.878601,"marketCap":98335064},{"date":"2024-07-05","current":-2.152746,"twenty":-3.658092,"median":-2.584246,"eighty":-1.878601,"marketCap":95979733},{"date":"2024-07-12","current":-2.154011,"twenty":-3.658092,"median":-2.579459,"eighty":-1.878601,"marketCap":96568566},{"date":"2024-07-15","current":-2.132266,"twenty":-3.658092,"median":-2.579459,"eighty":-1.878601,"marketCap":95979733},{"date":"2024-08-02","current":-2.012243,"twenty":-3.698487,"median":-2.587838,"eighty":-1.867194,"marketCap":89502573},{"date":"2024-08-09","current":-1.542577,"twenty":-3.698487,"median":-2.587838,"eighty":-1.851127,"marketCap":78903584},{"date":"2024-08-16","current":-1.543577,"twenty":-3.698487,"median":-2.587838,"eighty":-1.84579,"marketCap":79492417},{"date":"2024-08-23","current":-1.707365,"twenty":-3.698487,"median":-2.587838,"eighty":-1.84579,"marketCap":88913740},{"date":"2024-08-30","current":-1.882183,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":97746231},{"date":"2024-09-06","current":-1.77856,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":92446737},{"date":"2024-09-13","current":-1.638886,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":84791911},{"date":"2024-09-20","current":-1.7139,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":89502573},{"date":"2024-09-27","current":-1.730455,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":90680238},{"date":"2024-10-04","current":-1.77879,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":91857904},{"date":"2024-10-11","current":-1.678334,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":85969577},{"date":"2024-10-18","current":-1.797756,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":91269071},{"date":"2024-10-25","current":-1.86037,"twenty":-3.698487,"median":-2.587838,"eighty":-1.849356,"marketCap":94213235},{"date":"2024-10-31","current":-1.816024,"twenty":-3.698487,"median":-2.587838,"eighty":-1.849356,"marketCap":92446737},{"date":"2024-11-08","current":-1.75819,"twenty":-3.703273,"median":-2.588093,"eighty":-1.853721,"marketCap":88913740},{"date":"2024-11-15","current":-1.986236,"twenty":-3.703273,"median":-2.588093,"eighty":-1.85898,"marketCap":119533042},{"date":"2024-11-22","current":-2.032862,"twenty":-3.703273,"median":-2.588093,"eighty":-1.873049,"marketCap":121299540},{"date":"2024-11-29","current":-2.413842,"twenty":-3.703273,"median":-2.588093,"eighty":-1.881058,"marketCap":144852849},{"date":"2024-12-06","current":-2.409258,"twenty":-3.703273,"median":-2.588093,"eighty":-1.888141,"marketCap":144852849},{"date":"2024-12-13","current":-2.279807,"twenty":-3.703273,"median":-2.588093,"eighty":-1.905561,"marketCap":136020358},{"date":"2024-12-20","current":-2.123768,"twenty":-3.703273,"median":-2.588093,"eighty":-1.919808,"marketCap":125421369},{"date":"2024-12-27","current":-2.594259,"twenty":-3.703273,"median":-2.590889,"eighty":-1.928389,"marketCap":153685339},{"date":"2025-01-03","current":-2.523482,"twenty":-3.703273,"median":-2.593524,"eighty":-1.945481,"marketCap":147208180},{"date":"2025-01-10","current":-2.342961,"twenty":-3.70806,"median":-2.593617,"eighty":-1.957166,"marketCap":137198023},{"date":"2025-01-17","current":-2.564185,"twenty":-3.70806,"median":-2.593617,"eighty":-1.96758,"marketCap":150152343},{"date":"2025-01-24","current":-2.356442,"twenty":-3.70806,"median":-2.593617,"eighty":-1.978631,"marketCap":139553354},{"date":"2025-01-31","current":-2.353498,"twenty":-3.70806,"median":-2.593617,"eighty":-1.994331,"marketCap":139553354},{"date":"2025-02-07","current":-2.534146,"twenty":-3.70806,"median":-2.593617,"eighty":-2.012243,"marketCap":149563510},{"date":"2025-02-14","current":-2.676169,"twenty":-3.70806,"median":-2.594259,"eighty":-2.017073,"marketCap":158984834},{"date":"2025-02-21","current":-1.830033,"twenty":-3.70806,"median":-2.594259,"eighty":-2.016149,"marketCap":108934053},{"date":"2025-02-28","current":-1.342976,"twenty":-3.70806,"median":-2.594259,"eighty":-2.007413,"marketCap":79492417},{"date":"2025-03-07","current":-1.156608,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":71248759},{"date":"2025-03-14","current":-1.095804,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":67715762},{"date":"2025-03-21","current":-1.484361,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":74192922},{"date":"2025-03-28","current":-1.699421,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":84502137},{"date":"2025-04-04","current":-1.392072,"twenty":-3.708133,"median":-2.593524,"eighty":-1.978954,"marketCap":70981795},{"date":"2025-04-11","current":-1.180921,"twenty":-3.70806,"median":-2.588348,"eighty":-1.96758,"marketCap":60841539},{"date":"2025-04-17","current":-1.355089,"twenty":-3.70806,"median":-2.587838,"eighty":-1.958598,"marketCap":70981795},{"date":"2025-04-25","current":-1.706059,"twenty":-3.708133,"median":-2.586854,"eighty":-1.944521,"marketCap":89234257},{"date":"2025-05-02","current":-2.407629,"twenty":-3.708133,"median":-2.583083,"eighty":-1.926392,"marketCap":125063163},{"date":"2025-05-09","current":-2.118244,"twenty":-3.708133,"median":-2.577703,"eighty":-1.926392,"marketCap":106810701},{"date":"2025-05-16","current":-2.410655,"twenty":-3.708133,"median":-2.573155,"eighty":-1.926392,"marketCap":120589891},{"date":"2025-05-23","current":-2.443597,"twenty":-3.679696,"median":-2.568267,"eighty":-1.926392,"marketCap":123299776},{"date":"2025-05-30","current":-1.13339,"twenty":-3.647428,"median":-2.563851,"eighty":-1.913307,"marketCap":57591835},{"date":"2025-06-06","current":-1.123178,"twenty":-3.626423,"median":-2.55507,"eighty":-1.889126,"marketCap":57517313},{"date":"2025-06-13","current":-1.047083,"twenty":-3.626423,"median":-2.541295,"eighty":-1.880393,"marketCap":54197704},{"date":"2025-06-20","current":-1.054136,"twenty":-3.62668,"median":-2.538033,"eighty":-1.875322,"marketCap":54062209},{"date":"2025-06-27","current":-1.078148,"twenty":-3.62668,"median":-2.538033,"eighty":-1.847382,"marketCap":56406260},{"date":"2025-07-03","current":-1.03345,"twenty":-3.62668,"median":-2.538033,"eighty":-1.835407,"marketCap":54360297},{"date":"2025-07-11","current":-1.160295,"twenty":-3.62668,"median":-2.538033,"eighty":-1.822354,"marketCap":60647230},{"date":"2025-07-18","current":-1.134508,"twenty":-3.62668,"median":-2.538033,"eighty":-1.809629,"marketCap":58797734},{"date":"2025-07-25","current":-1.094112,"twenty":-3.62668,"median":-2.538033,"eighty":-1.799033,"marketCap":57591835},{"date":"2025-08-01","current":-1.198497,"twenty":-3.62668,"median":-2.538033,"eighty":-1.790625,"marketCap":61311152},{"date":"2025-08-08","current":-1.048287,"twenty":-3.62668,"median":-2.538033,"eighty":-1.779579,"marketCap":55220685},{"date":"2025-08-15","current":-1.062121,"twenty":-3.62668,"median":-2.538033,"eighty":-1.773402,"marketCap":56047200},{"date":"2025-08-22","current":-1.15665,"twenty":-3.62668,"median":-2.538033,"eighty":-1.764837,"marketCap":60836922},{"date":"2025-08-29","current":-1.500694,"twenty":-3.62668,"median":-2.538033,"eighty":-1.751777,"marketCap":79264142},{"date":"2025-09-05","current":-2.017509,"twenty":-3.626938,"median":-2.538234,"eighty":-1.751639,"marketCap":106362994},{"date":"2025-09-12","current":-1.872294,"twenty":-3.62668,"median":-2.538033,"eighty":-1.751777,"marketCap":99588281},{"date":"2025-09-19","current":-1.738574,"twenty":-3.62668,"median":-2.538033,"eighty":-1.741257,"marketCap":92813568},{"date":"2025-09-26","current":-1.652681,"twenty":-3.62668,"median":-2.538033,"eighty":-1.733002,"marketCap":87393797},{"date":"2025-10-03","current":-1.764269,"twenty":-3.62668,"median":-2.538033,"eighty":-1.729865,"marketCap":93491039},{"date":"2025-10-10","current":-1.888603,"twenty":-3.62668,"median":-2.538033,"eighty":-1.729865,"marketCap":98910809},{"date":"2025-10-17","current":-1.589181,"twenty":-3.62668,"median":-2.538033,"eighty":-1.715896,"marketCap":84006441},{"date":"2025-10-24","current":-1.572126,"twenty":-3.62668,"median":-2.538033,"eighty":-1.710768,"marketCap":82651498},{"date":"2025-10-31","current":-1.707503,"twenty":-3.62668,"median":-2.536982,"eighty":-1.708857,"marketCap":89426211},{"date":"2025-11-07","current":-1.555866,"twenty":-3.62668,"median":-2.534146,"eighty":-1.707448,"marketCap":81296556},{"date":"2025-11-14","current":-1.842931,"twenty":-3.62668,"median":-2.532153,"eighty":-1.706843,"marketCap":86038855},{"date":"2025-11-21","current":-1.683561,"twenty":-3.62668,"median":-2.529404,"eighty":-1.704879,"marketCap":77909199},{"date":"2025-11-28","current":-1.835231,"twenty":-3.62668,"median":-2.52731,"eighty":-1.704879,"marketCap":85361383},{"date":"2025-12-05","current":-1.593453,"twenty":-3.62668,"median":-2.52731,"eighty":-1.699337,"marketCap":74521843},{"date":"2025-12-12","current":-1.46602,"twenty":-3.62668,"median":-2.519124,"eighty":-1.679502,"marketCap":69102072},{"date":"2025-12-19","current":-1.524944,"twenty":-3.62668,"median":-2.509756,"eighty":-1.667406,"marketCap":71811957},{"date":"2025-12-26","current":-1.634642,"twenty":-3.62668,"median":-2.502779,"eighty":-1.658358,"marketCap":77231728},{"date":"2026-01-02","current":-1.452671,"twenty":-3.62668,"median":-2.494862,"eighty":-1.654063,"marketCap":68424601},{"date":"2026-01-09","current":-1.580071,"twenty":-3.62668,"median":-2.49125,"eighty":-1.646849,"marketCap":73844371},{"date":"2026-01-16","current":-1.455182,"twenty":-3.615874,"median":-2.479169,"eighty":-1.636099,"marketCap":67747130},{"date":"2026-01-23","current":-1.480915,"twenty":-3.615874,"median":-2.472232,"eighty":-1.62913,"marketCap":69779543},{"date":"2026-01-30","current":-1.306377,"twenty":-3.615874,"median":-2.463946,"eighty":-1.611667,"marketCap":62510276},{"date":"2026-02-06","current":-1.182562,"twenty":-3.615874,"median":-2.454336,"eighty":-1.599547,"marketCap":55918481}],"updateTime":1770487217853},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IFRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609591184","title":"Here's Why We're A Bit Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591184","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609591184?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:42","pubTimestamp":1770374554,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ifrx/inflarx/news/heres-why-were-a-bit-worried-about-inflarxs-nasdaqifrx-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ifrx/inflarx/news/heres-why-were-a-bit-worried-about-inflarxs-nasdaqifrx-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TQQQ","SQQQ","USAW.SI","PSQ","QID","TSYW.SI","BK4139",".IXIC","QYLD","QQQJ","QYLG","JEPQ","QQQY","NQmain","QQQE","MNQmain","QLD","IFRX","GPIQ","USJW.SI","NVIW.SI"],"gpt_icon":1},{"id":"2609391777","title":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), InflaRx (IFRX) and Verastem (VSTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609391777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609391777?lang=en_us&edition=fundamental","pubTime":"2026-02-05 01:30","pubTimestamp":1770226221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Voyager Therapeutics (VYGR – Research Report), Infla...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-inflarx-ifrx-and-verastem-vstm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-inflarx-ifrx-and-verastem-vstm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IFRX","LU0128526141.USD","LABU","BK4581","BK4588","BK4585","BK4139","HCSG","XLV","VSTM","VYGR","BK4137","LU0029874061.USD","XBI"],"gpt_icon":0},{"id":"2607886082","title":"InflaRx NV to Present at Guggenheim Securities Emerging Outlook Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2607886082","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607886082?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:30","pubTimestamp":1769689812,"startTime":"0","endTime":"0","summary":"InflaRx NV will participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 on February 11-12, 2026, in New York, NY, featuring a fireside chat on February 11 at 11:30 AM ET. The company will also take part in the Oppenheimer 36th Annual Healthcare Life Sciences Conference, held virtually on February 25-26, 2026, with a virtual presentation scheduled for February 25 at 8:40 AM ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the original content used to generate this news brief via GlobeNewswire  on January 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL3DP2L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","IFRX","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4585","LU2095319765.USD","BK4588","BK4139","NDAQ"],"gpt_icon":0},{"id":"2602734391","title":"InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2602734391","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602734391?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:22","pubTimestamp":1767892920,"startTime":"0","endTime":"0","summary":"InflaRx outlines restructuring plans, workforce cuts, and reduced Gohibic spending to extend cash runway and focus development efforts on izicopan through mid-2027.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/08/biotech-lab.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/08/biotech-lab.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49791962/inflarx-plans-workforce-reduction-targets-mid-2027-cash-runway","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49791962/inflarx-plans-workforce-reduction-targets-mid-2027-cash-runway","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ARDS","IFRX","BK4139"],"gpt_icon":0},{"id":"2601643123","title":"InflaRx NV to Prioritize Izicopan Development in Hidradenitis Suppurativa and I&I, Plans Workforce Reduction, China PK Bridging Study, and Cost Structure Optimization to Extend Cash Runway to Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2601643123","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601643123?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877225,"startTime":"0","endTime":"0","summary":"InflaRx NV to Prioritize Izicopan Development in Hidradenitis Suppurativa and I&I, Plans Workforce Reduction, China PK Bridging Study, and Cost Structure Optimization to Extend Cash Runway to Mid-2027. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3zLgdY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4112","LU0314104364.USD","LU2210149790.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014013.SGD","BK4585","SG9999014039.USD","IFRX","LU2210150020.SGD","NDAQ","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2601129886","title":"InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2601129886","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601129886?lang=en_us&edition=fundamental","pubTime":"2026-01-05 20:08","pubTimestamp":1767614880,"startTime":"0","endTime":"0","summary":"InflaRx N.V.  is reviving hopes for vilobelimab after new analyses showed signs of efficacy in a Phase 3 trial it had previously halted, setting up FDA talks and a potential partner-led path forward.Last Tuesday, the company outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum , which was terminated earlier in 2025 after an Independent Data Monitoring Committee  recommended the trial be stopped early due to futility.Subsequent post-hoc analyses suggest a positive trend in favor of vilobelimab, with signals indicating a potentially consistent treatment effect, the company said.Pyoderma gangrenosum  is a rare, painful skin condition characterized by red bumps that quickly develop into large, deep, open ulcers, often with a purple, undermined border, although it’s not caused by infection or gangrene.In addition, patients reported feeling better as measured by the Dermatology Life Quality Index  mean percentage change at the end of the treatment visi","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/05/Medical-Research-And-Development-Center-.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/05/Medical-Research-And-Development-Center-.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/01/49687006/inflarx-reopens-case-for-axed-phase-3-drug-for-rare-skin-disorder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49687006/inflarx-reopens-case-for-axed-phase-3-drug-for-rare-skin-disorder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU0234572021.USD","SG9999001440.SGD","LU0061475181.USD","BK4018","PG","BK4534","LU1868836757.USD","IE000M9KFDE8.USD","GB00BDT5M118.USD","LU0942090050.USD","BK4504","BK4139","LU0323591593.USD","LU1430594728.SGD","LU1280957306.USD","LU0640476718.USD","LU2129689605.HKD","LU1868836914.USD","LU0868494708.USD","LU0124676726.USD","LU1585245621.USD","LU1868836591.USD","BK4585","IE00B1XK9C88.USD","BK4558","SG9999002232.USD","SG9999015358.SGD","SG9999014575.USD","LU1868837136.USD","IE00BWXC8680.SGD","LU0098860793.USD","LU1914381329.SGD","BK4567","LU1929549753.HKD","IE00BBT3K403.USD","LU0094547139.USD","LU2129689514.USD","IFRX","LU2552382215.SGD","LU2129689431.USD","SG9999014542.SGD","BK4559","LU0320765646.SGD","LU1868837300.USD","SG9999015341.SGD","BK4533","LU2552382058.USD","LU2097829019.USD","LU1066051498.USD","LU1162221912.USD"],"gpt_icon":0},{"id":"2595715102","title":"InflaRx Price Target Maintained With a $6.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2595715102","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595715102?lang=en_us&edition=fundamental","pubTime":"2025-12-30 23:45","pubTimestamp":1767109500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2025 10:45 ET (15:45 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2595790563","title":"Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum","url":"https://stock-news.laohu8.com/highlight/detail?id=2595790563","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595790563?lang=en_us&edition=fundamental","pubTime":"2025-12-30 21:42","pubTimestamp":1767102129,"startTime":"0","endTime":"0","summary":"Dec 30 (Reuters) - InflaRx NV ::*INFLARX PROVIDES UPDATE ON PHASE 3 DATA ANALYSES FOR VILOBELIMAB IN PYODERMA GANGRENOSUM*INFLARX NV - PHASE 3 TRIAL OF VILOBELIMAB TERMINATED DUE TO FUTILITY*INFLARX N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nRSD3JcWQl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2595079230","title":"InflaRx Reviews Phase 3 Data for Vilobelimab in Pyoderma Gangrenosum After Early Trial Termination","url":"https://stock-news.laohu8.com/highlight/detail?id=2595079230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595079230?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097820,"startTime":"0","endTime":"0","summary":"InflaRx N.V. has provided an update on the Phase 3 clinical study of vilobelimab for the treatment of pyoderma gangrenosum . The trial was terminated earlier in the year after an Independent Data Monitoring Committee recommended stopping the study due to futility with respect to its prespecified primary endpoint. Subsequent post-hoc analyses of the 54 enrolled patients indicate a positive trend in favor of vilobelimab, particularly in terms of ulcer volume reduction. InflaRx has disclosed these data analyses and anticipates meeting with the FDA to discuss potential future development paths for vilobelimab in PG, including the possibility of using alternative clinical endpoints. The company has stated that any further development in this indication would likely occur in collaboration with a partner.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLvkRpK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IFRX","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014013.SGD","LU0314104364.USD","BK4588","NDAQ","LU2095319765.USD","IE00BKPKM429.USD","SG9999014021.USD","SG9999014005.SGD","BK4585","SG9999014039.USD","BK4139","LU2210150020.SGD"],"gpt_icon":0},{"id":"2582748378","title":"InflaRx Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2582748378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582748378?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:22","pubTimestamp":1762780920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 08:22 ET (13:22 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2582765498","title":"InflaRx Reports Positive Phase 2a Results for INF904 in HS and CSU","url":"https://stock-news.laohu8.com/highlight/detail?id=2582765498","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582765498?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:37","pubTimestamp":1762778223,"startTime":"0","endTime":"0","summary":"InflaRx N.V. has announced positive topline data from a Phase 2a basket study evaluating its anti-inflammatory therapeutic candidate, INF904, in patients with hidradenitis suppurativa  and chronic spontaneous urticaria . The study reported efficacy data from 29 of 31 HS patients and 30 of 31 CSU patients, with further results expected after completion of a 4-week post-treatment observation period. In CSU patients, the company observed substantial reductions in the 7-day Urticaria Activity Score  and improvements in the Urticaria Control Test . InflaRx plans to initiate a Phase 2b trial in HS in 2026 and continues to enroll patients in a third CSU dosing cohort. Final results from the Phase 2a study are scheduled for presentation at upcoming major scientific meetings. The company hosted a webcast to discuss the topline data and will hold additional events to further showcase INF904.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDLbGbyMg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2580755155","title":"InflaRx NV  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580755155","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580755155?lang=en_us&edition=fundamental","pubTime":"2025-11-04 23:16","pubTimestamp":1762269379,"startTime":"0","endTime":"0","summary":"InflaRx NV  expected to post a loss of15cents a share - Earnings Preview InflaRx NV IFRX.OQ, IFRX.O is expected to  show a fall in quarterly revenue when it reports  results on November 6 (estimated) ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL8N3WG2AT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2573951892","title":"InflaRx (IFRX) Receives a Buy from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2573951892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573951892?lang=en_us&edition=fundamental","pubTime":"2025-10-07 18:36","pubTimestamp":1759833397,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Joseph Schwartz from Leerink Partners reiterated a Buy rating on InflaRx, with a price target of $2.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inflarx-ifrx-receives-a-buy-from-leerink-partners-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inflarx-ifrx-receives-a-buy-from-leerink-partners-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2568836473","title":"H.C. Wainwright Remains a Buy on InflaRx (IFRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568836473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568836473?lang=en_us&edition=fundamental","pubTime":"2025-09-18 17:36","pubTimestamp":1758188208,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Keller maintained a Buy rating on InflaRx yesterday and set a price target of $6.00. The company’s shares closed ye...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-inflarx-ifrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-inflarx-ifrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2566977971","title":"InflaRx regains compliance with Nasdaq min bid price requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566977971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566977971?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:35","pubTimestamp":1757680527,"startTime":"0","endTime":"0","summary":"InflaRx (IFRX) announced that it has received a written notice, dated September 11, 2025, from the Listing Qualifications Department of The Nasdaq ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inflarx-regains-compliance-with-nasdaq-min-bid-price-requirement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inflarx-regains-compliance-with-nasdaq-min-bid-price-requirement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USJW.SI","BK4588","MNQmain","LU2210149790.SGD","SQQQ","QID","NQmain","BK4585","LU2095319765.USD","LU2210150020.SGD","NDAQ","PSQ","LU0314104364.USD","IE00BKPKM429.USD","IFRX","IE00B64PRP62.GBP",".IXIC","IE00BGHQF748.EUR","QLD","USAW.SI","TQQQ","TSYW.SI","IE00B3QW5Z07.USD","NVIW.SI","BK4112","BK4139"],"gpt_icon":0},{"id":"2564806250","title":"InflaRx Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2564806250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564806250?lang=en_us&edition=fundamental","pubTime":"2025-09-02 18:57","pubTimestamp":1756810620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 02, 2025 06:57 ET (10:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2564803086","title":"InflaRx Nv : H.c. Wainwright Assumes Coverage With Buy Rating; Price Target $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2564803086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564803086?lang=en_us&edition=fundamental","pubTime":"2025-09-02 18:13","pubTimestamp":1756808039,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nFWN3UP0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IFRX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}